When will the corruption stop? CanLyme is a member of the Ad Hoc Committee for Health Equity.
“A request to have ‘Congenital Lyme borreliosis’ listed as a ‘stand-alone’ category in the new ICD-11 codes was made by the Ad Hoc Committee for Health Equity in ICD-11 Borreliosis Codes, submitted March 27, 2017 by Jenna Luché-Thayer and other authors. Following a WHO directed scientific review, the code 1C1G.2, for ‘Congenital Lyme borreliosis’, was released as part of WHO’s June 2018 announcement of ‘stable codes‘ – meaning they had been thoroughly vetted and accepted as stable.” See Ad Hoc
Then, without transparent discussion or debate the code for congenital Lyme disease was removed.
“This was in response to a request for the removal of Congenital Lyme borreliosis by the Public Health Agency of Canada (PHAC) …”
The World Health Organization (WHO) says it was Canada who asked for it to be removed. Canada denied this while providing no proof and allowing no independent investigation into to what was an obvious breach of Canada’s and WHO’s own policy. NICE is the United Kingdom’s version of PHAC and they are not independent of each other. This is the fox doing the foxes bidding at taxpayers expense yet again.
We Canadian taxpayers fund our country’s contribution to the WHO and we must insist that our elected members act in our best interest, not in the interest of the global for-profit medical industry which is what is driving current international Lyme disease policy in a very monopolistic fashion.